Tracking the effectiveness of vaccines for respiratory and gastrointestinal diseases in children
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
This study is looking at how well vaccines work to protect young children from illnesses like the flu and stomach bugs, so we can better understand their impact and improve vaccination strategies in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10669094 on NIH RePORTER |
What this research studies
This research focuses on monitoring and evaluating the effectiveness of vaccines against acute respiratory illness (ARI) and acute gastroenteritis (AGE) in young children. It aims to identify the burden of these diseases, the pathogens responsible, and the impact of vaccination strategies. By conducting rigorous surveillance, the study will assess how well vaccines protect against diseases like influenza and SARS-CoV-2, which are critical for public health. The findings will help inform future vaccination strategies and improve vaccine effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children, particularly those who are at higher risk for ARI and AGE.
Not a fit: Patients who are not children or those who have already been vaccinated against the specific pathogens being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies that significantly reduce the incidence of severe respiratory and gastrointestinal diseases in children.
How similar studies have performed: Previous research has shown success in monitoring vaccine effectiveness for similar diseases, indicating that this approach is both valid and necessary.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Halasa, Natasha Bassam — Vanderbilt University Medical Center
- Study coordinator: Halasa, Natasha Bassam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.